The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2S)-2-[[(1S)-1-carboxy-5-[[4-[[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]methyl]benzoyl]amino]pentyl]carbamoylamino]pentanedioic acid ID: ALA5279851
Max Phase: Preclinical
Molecular Formula: C36H54N8O15
Molecular Weight: 838.87
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)c1ccc(CNC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)cc1)C(=O)O)C(=O)O
Standard InChI: InChI=1S/C36H54N8O15/c45-28(20-41-11-13-42(21-30(48)49)15-17-44(23-32(52)53)18-16-43(14-12-41)22-31(50)51)38-19-24-4-6-25(7-5-24)33(54)37-10-2-1-3-26(34(55)56)39-36(59)40-27(35(57)58)8-9-29(46)47/h4-7,26-27H,1-3,8-23H2,(H,37,54)(H,38,45)(H,46,47)(H,48,49)(H,50,51)(H,52,53)(H,55,56)(H,57,58)(H2,39,40,59)/t26-,27-/m0/s1
Standard InChI Key: QGSSCKQGHNZORO-SVBPBHIXSA-N
Molfile:
RDKit 2D
59 60 0 0 0 0 0 0 0 0999 V2000
21.1372 -21.5372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8517 -21.1247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4228 -21.1247 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.1372 -22.3622 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.5662 -21.5372 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.8517 -20.2998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5662 -19.8873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5662 -19.0623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2807 -18.6498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2807 -17.8248 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.2807 -21.1247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9952 -21.5372 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.2807 -20.2998 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.7096 -21.1247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4241 -21.5372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7096 -20.2998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4241 -19.8873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4241 -19.0623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1384 -18.6460 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.7095 -18.6460 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.4274 -22.3640 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.1420 -21.1265 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.0026 -17.4100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0079 -16.5838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7253 -16.1740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7305 -15.3478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0146 -14.9294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0220 -14.0995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7394 -13.6897 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.2973 -15.3391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2920 -16.1653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7184 -17.8285 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.4644 -14.0834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1678 -13.6523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4862 -14.9081 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.1462 -12.8275 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.8495 -12.3964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4210 -12.4339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3993 -11.6092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5745 -12.7900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2780 -12.3588 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.2562 -11.5341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5311 -11.1406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5095 -10.3158 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.1008 -11.1727 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.0736 -10.3481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7740 -9.9123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0030 -12.7523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0247 -13.5770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3232 -14.0107 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.7516 -13.9731 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.2138 -9.8863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9380 -10.2815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9604 -11.1054 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.6449 -9.8511 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.4989 -10.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4741 -9.7754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1736 -9.3404 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.7453 -9.3833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
1 4 1 0
2 5 1 0
2 6 1 6
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
5 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 1 0
14 16 1 1
16 17 1 0
17 18 1 0
18 19 1 0
18 20 2 0
15 21 1 0
15 22 2 0
10 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 1 0
27 30 1 0
30 31 2 0
24 31 1 0
23 32 2 0
29 33 1 0
33 34 1 0
33 35 2 0
34 36 1 0
36 37 1 0
36 38 1 0
38 39 1 0
37 40 1 0
40 41 1 0
41 42 1 0
42 43 1 0
43 44 1 0
39 45 1 0
45 46 1 0
46 47 1 0
47 44 1 0
41 48 1 0
48 49 1 0
49 50 1 0
49 51 2 0
44 52 1 0
52 53 1 0
53 54 1 0
53 55 2 0
45 56 1 0
56 57 1 0
57 58 1 0
57 59 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 838.87Molecular Weight (Monoisotopic): 838.3709AlogP: -2.25#Rotatable Bonds: 23Polar Surface Area: 336.09Molecular Species: ZWITTERIONHBA: 13HBD: 10#RO5 Violations: 3HBA (Lipinski): 23HBD (Lipinski): 10#RO5 Violations (Lipinski): 3CX Acidic pKa: 1.25CX Basic pKa: 8.97CX LogP: -6.19CX LogD: -21.58Aromatic Rings: 1Heavy Atoms: 59QED Weighted: 0.05Np Likeness Score: -0.56
References 1. Chia CSB.. (2023) Novel PSMA-Targeting Radionuclide Peptidomimetics for Treating Prostate Cancer., 14 (1.0): [PMID:36655127 ] [10.1021/acsmedchemlett.2c00510 ] 2. Benešová M, Bauder-Wüst U, Schäfer M, Klika KD, Mier W, Haberkorn U, Kopka K, Eder M.. (2016) Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors., 59 (5): [PMID:26878194 ] [10.1021/acs.jmedchem.5b01210 ]